Calcium Phosphate and Incretins

University of Jena

Status: Completed

Conditions: Healthy Men

Treatments: Dietary Supplement: calcium phosphate; Other: placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT01296997

LSEP H45-10

Details and patient eligibility

About

The study was conducted to investigate the effect of a calcium phosphate supplementation on the secretion of incretins.

Enrollment: 10 patients

Sex: Male

Ages: 20 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy men

Exclusion criteria

• intake of dietary supplements and chronic diseases

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Quadruple Blind

---

10 participants in 2 patient groups, including a placebo group

calcium phosphate

Experimental group

Treatment:

Dietary Supplement: calcium phosphate

placebo

Placebo Comparator group

Treatment:

Other: placebo